TrialNeurology2021

Efficacy and Safety of Bimagrumab in Sporadic Inclusion Body Myositis: Long-term Extension of RESILIENT.

Anthony A Amato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.